Literature DB >> 15342932

Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion.

Melissa A Baxter1, Robert F Wynn, Simon N Jowitt, J Ed Wraith, Leslie J Fairbairn, Ilaria Bellantuono.   

Abstract

Human marrow stromal cells (MSCs) can be isolated from bone marrow and differentiate into multiple tissues in vitro and in vivo. These properties make them promising tools in cell and gene therapy. The lack of a specific MSC marker and the low frequency of MSCs in bone marrow necessitate their isolation by in vitro expansion prior to clinical use. This may severely reduce MSC proliferative capacity to the point that the residual proliferative potential is insufficient to maintain long-term tissue regeneration upon reinfusion. In this study we determined the effect of in vitro expansion on the replicative capacity of MSCs by correlating their rate of telomere loss during in vitro expansion with their behavior in vivo. We report that even protocols that involve minimal expansion induce a rapid aging of MSCs, with losses equivalent to about half their total replicative lifespan.

Entities:  

Mesh:

Year:  2004        PMID: 15342932     DOI: 10.1634/stemcells.22-5-675

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  259 in total

1.  PKNOX2 expression and regulation in the bone marrow mesenchymal stem cells of Fanconi anemia patients and healthy donors.

Authors:  Ilgin Cagnan; Erdal Cosgun; Ozlen Konu; Duygu Uckan; Aysen Gunel-Ozcan
Journal:  Mol Biol Rep       Date:  2018-12-04       Impact factor: 2.316

2.  Changes of the Functional Capacity of Mesenchymal Stem Cells due to Aging or Age-Associated Disease - Implications for Clinical Applications and Donor Recruitment.

Authors:  Günter Lepperdinger; Regina Brunauer; Robert Gassner; Angelika Jamnig; Frank Kloss; Gerhard Thomas Laschober
Journal:  Transfus Med Hemother       Date:  2008-07-17       Impact factor: 3.747

3.  Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture.

Authors:  D S Yoon; Y H Kim; H S Jung; S Paik; J W Lee
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

Review 4.  Bone marrow mesenchymal stem cells: historical overview and concepts.

Authors:  Pierre Charbord
Journal:  Hum Gene Ther       Date:  2010-09       Impact factor: 5.695

Review 5.  Mesenchymal stem cells in the pathogenesis and therapy of breast cancer.

Authors:  Christelle P El-Haibi; Antoine E Karnoub
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-12-21       Impact factor: 2.673

Review 6.  Age-associated changes in regenerative capabilities of mesenchymal stem cell: impact on chronic wounds repair.

Authors:  Bin Yao; Sha Huang; Dongyun Gao; Jiangfan Xie; Nanbo Liu; Xiaobing Fu
Journal:  Int Wound J       Date:  2015-10-01       Impact factor: 3.315

7.  Bone transplantation and tissue engineering, part IV. Mesenchymal stem cells: history in orthopedic surgery from Cohnheim and Goujon to the Nobel Prize of Yamanaka.

Authors:  Philippe Hernigou
Journal:  Int Orthop       Date:  2015-03-07       Impact factor: 3.075

8.  Fracture repair in the elderly: Clinical and experimental considerations.

Authors:  E G Meinberg; D Clark; K R Miclau; R Marcucio; T Miclau
Journal:  Injury       Date:  2019-05-11       Impact factor: 2.586

9.  Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro.

Authors:  Lauren V Schnabel; Christian M Abratte; John C Schimenti; M Julia Bevilaqua Felippe; Jennifer M Cassano; Teresa L Southard; Jessica A Cross; Lisa A Fortier
Journal:  Regen Med       Date:  2014-04-28       Impact factor: 3.806

10.  The safety and efficacy of magnetic targeting using autologous mesenchymal stem cells for cartilage repair.

Authors:  Naosuke Kamei; Mitsuo Ochi; Nobuo Adachi; Masakazu Ishikawa; Shinobu Yanada; L Scott Levin; Goki Kamei; Takaaki Kobayashi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2018-03-16       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.